Altrinsic Global Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History

Altrinsic Global Advisors’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-41,168	Closed	-$3.99M	–	83
2018 Q3	$3.99M	Sell	41,168 -15,000	-27%	-$1.5M	0.18%	48
2018 Q2	$5.29M	Hold	56,168	–	–	0.21%	48
2018 Q1	$4.55M	Hold	56,168	–	–	0.18%	48
2017 Q4	$5.01M	Buy	56,168 +11,000	+24%	+$956K	0.19%	49
2017 Q3	$4.2M	Hold	45,168	–	–	0.16%	57
2017 Q2	$4.1M	Hold	45,168	–	–	0.15%	59
2017 Q1	$3.96M	Sell	45,168 -5,000	-10%	-$445K	0.13%	57
2016 Q4	$4.16M	Sell	50,168 -20,000	-29%	-$1.72M	0.15%	58
2016 Q3	$6.49M	Hold	70,168	–	–	0.24%	51
2016 Q2	$5.46M	Sell	70,168 -15,000	-18%	-$1.28M	0.15%	55
2016 Q1	$7.03M	Hold	85,168	–	–	0.2%	54
2015 Q4	$8.92M	Sell	85,168 -12,000	-12%	-$1.25M	0.23%	53
2015 Q3	$10.2M	Sell	97,168 -171,001	-64%	-$22.8M	0.24%	52
2015 Q2	$36.7M	Sell	268,169 -120,057	-31%	-$14.9M	0.75%	44
2015 Q1	$48.4M	Sell	388,226 -324,992	-46%	-$34.4M	1.05%	33
2014 Q4	$64.5M	Sell	713,218 -930,714	-57%	-$77.4M	1.33%	29
2014 Q3	$119M	Sell	1,643,932 -190,054	-10%	-$12.5M	2.24%	19
2014 Q2	$114M	Buy	1,833,986 +5,408	+0.3%	+$327K	2.01%	20
2014 Q1	$125M	Sell	1,828,578 -250,765	-12%	-$18.5M	2.14%	19
2013 Q4	$146M	Sell	2,079,343 -107,839	-5%	-$7.32M	2.55%	18
2013 Q3	$158M	Sell	2,187,182 -283,601	-11%	-$18.8M	2.69%	12
2013 Q2	$138M	Buy	+2,470,783	New	+$154M	2.38%	19

Other funds holding BMRN

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Altrinsic Global Advisors's BMRN Position: Q4 2018 in Review

Altrinsic Global Advisors sold out of BioMarin Pharmaceuticals (BMRN) in Q4 2018, closing a stake of 41,168 shares — an estimated $3.99M sold.

Altrinsic Global Advisors first reported a position in BMRN in Q2 2013 and held it in 22 quarters. The position peaked at $158M in Q3 2013. 472 funds tracked by Wall St. Rank hold BMRN as of Q4 2018.

Altrinsic Global Advisors reported no remaining BioMarin Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
Altrinsic Global Advisors sold 41,168 BioMarin Pharmaceuticals shares in Q4 2018, an estimated $3.99M.
Altrinsic Global Advisors first reported a position in BioMarin Pharmaceuticals in Q2 2013 and held it in 22 quarters.
Altrinsic Global Advisors's BioMarin Pharmaceuticals position peaked at $158M in Q3 2013.
472 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q4 2018.

Based on Altrinsic Global Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.